UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000008456 |
|---|---|
| Receipt number | R000009941 |
| Scientific Title | Functional linkage between the genetic polymorphisms of innate immunity regulatory genes and diseases in Japanese subjects. |
| Date of disclosure of the study information | 2012/07/19 |
| Last modified on | 2012/07/19 19:21:09 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Functional linkage between the genetic polymorphisms of innate immunity regulatory genes and diseases in Japanese subjects.
Acronym
Genetic polymorphisms of innate immunity regulatory genes
Scientific Title
Functional linkage between the genetic polymorphisms of innate immunity regulatory genes and diseases in Japanese subjects.
Scientific Title:Acronym
Genetic polymorphisms of innate immunity regulatory genes
Region
| Japan |
Condition
Condition
heart disease,connective tissue disease, uveitis, Adult T cell Leukemia, human T-cell leukemia virus type 1-carriers, healthy subject
Classification by specialty
| Cardiology | Hematology and clinical oncology | Clinical immunology |
| Ophthalmology | Cardiovascular surgery |
Classification by malignancy
Others
Genomic information
YES
Objectives
Narrative objectives1
Functional linkage between the genetic polymorphisms of innate immunity regulatory genes and diseases in Japanese subjects.
Basic objectives2
Others
Basic objectives -Others
Single nucleotide polymorphism analysis of innate immunity regulatory genes
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
Single nucleotide polymorphism
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1)heart disease,connective tissue disease, uveitis, Adult T cell Leukemia, human T-cell leukemia virus type 1-carriers, healthy subject
2)Patients who provided written informed consents to participate the study prior to enrollment
Key exclusion criteria
Other conditions considered inappropriate by attending physician
Target sample size
520
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Akira Nishizono |
Organization
Oita University Faculty of Medicine
Division name
Department of Microbiology
Zip code
Address
1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita 879-5593, Japan
TEL
097-586-5712
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Satoko Nakano |
Organization
Oita University Faculty of Medicine
Division name
Department of Microbiology
Zip code
Address
1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita 879-5593, Japan
TEL
097-586-5712
Homepage URL
oita_microbio-admin@umin.ac.jp
Sponsor or person
Institute
Department of Microbiology, Oita University Faculty of Medicine
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
大分大学医学部附属病院(大分県)
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 07 | Month | 19 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2012 | Year | 04 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2012 | Year | 07 | Month | 19 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Single nucleotide polymorphism
Management information
Registered date
| 2012 | Year | 07 | Month | 17 | Day |
Last modified on
| 2012 | Year | 07 | Month | 19 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009941
